General Ledger (GL) Accountant at Orca Bio

Menlo Park, California, United States

Orca Bio Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • Bachelor’s degree in accounting, finance, or related field
  • 4+ years of general accounting experience, ideally in a public company or biotech setting
  • Solid understanding of GAAP, internal controls, and SOX compliance requirements
  • Proficiency with NetSuite
  • Advanced Excel skills (pivot tables, VLOOKUP)
  • Ability to analyze data, solve problems independently, and propose process improvements
  • Strong attention to detail and ability to meet deadlines

Responsibilities

  • Prepare journal entries for cash, investment, accruals, prepayments, reclassifications, and other adjustments
  • Maintain fixed asset registers, including recording acquisition, disposal, and calculating depreciation
  • Perform balance sheet account reconciliation and resolve any discrepancies on a monthly basis
  • Ensure compliance with internal controls, GAAP, and SOX policies
  • Assist with 1099 reporting and year-end tax filings for vendors
  • Support monthly, quarterly, and year-end close processes, including variance analysis
  • Assist internal and external audit by providing schedules, documentation and explanation as needed
  • Help optimize systems and tools for scalability as the company grows

Skills

Journal Entries
Fixed Assets
Depreciation
Balance Sheet Reconciliation
GAAP
SOX Compliance
Month-End Close
Variance Analysis
1099 Reporting
Audit Support

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI